DanCann Pharma A/S (NGM: DANCAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in DKK
0.0076
+0.0002 (2.70%)
At close: Sep 6, 2024

DanCann Pharma Cash Flow Statement

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-59.11-62.26-16.06-11.75-4.26-0.5
Depreciation & Amortization
3.263.382.230.890.090.01
Asset Writedown & Restructuring Costs
43.8443.84----
Other Operating Activities
3.721.493.24-3.21-1.71-0.14
Change in Accounts Receivable
4.072.88-0.141.78-4.87-0.09
Change in Inventory
0.320-0.07-0.04-0.01-
Change in Other Net Operating Assets
-9.78-1.37-0.920.343.080.47
Operating Cash Flow
-13.56-12.03-11.73-11.99-7.66-0.26
Capital Expenditures
-0.01-0.01-1.01-6.37-4.02-0.06
Sale of Property, Plant & Equipment
-0.49--0.16--
Sale (Purchase) of Intangibles
-1.02-4.03-7.26-26.03-14.74-0.95
Other Investing Activities
-----0.32-
Investing Cash Flow
-1.51-4.04-8.27-32.25-19.07-1.01
Short-Term Debt Issued
-----1.46
Long-Term Debt Issued
-6.215.0710.180.19-
Total Debt Issued
8.456.215.0710.180.191.46
Short-Term Debt Repaid
-----0.55-
Long-Term Debt Repaid
--3.22-7.54-0.33-0.96-
Total Debt Repaid
0.37-3.22-7.54-0.33-1.5-
Net Debt Issued (Repaid)
8.823-2.479.84-1.321.46
Issuance of Common Stock
5.65.631.2321.4653.880
Other Financing Activities
-1.27-1.27-5.74-0.67-4.67-
Financing Cash Flow
13.157.3323.0130.6447.891.46
Miscellaneous Cash Flow Adjustments
--0---
Net Cash Flow
-1.92-8.753.02-13.621.150.19
Free Cash Flow
-13.57-12.04-12.74-18.36-11.68-0.32
Free Cash Flow Margin
-165.09%-168.33%-177.16%-796.31%--
Free Cash Flow Per Share
-0.02-0.09-0.20-0.81-1.32-
Cash Income Tax Paid
--1.47-5.42-0.21--
Levered Free Cash Flow
-28.98-36.68-25.14-32.07-28.78-
Unlevered Free Cash Flow
-27.61-35.22-23.25-31.29-28.69-
Change in Net Working Capital
-5.27-3.016.95-9.296.37-
Source: S&P Capital IQ. Standard template. Financial Sources.